![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Tidilan is currently available in tablet and injectable dosage forms. BSV has some of the leading women’s health brands such as Rhoclone, Hucog, Hucog 5000 HP, AntiD among others.
Lead Product(s): Isoxsuprine Hydrochloride
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Tidilan
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Bharat Serums & Vaccines ltd
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 05, 2022